DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Welt A, Marschner N, Lerchenmueller C. et al.
Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial.
Breast Cancer Res Treat 2016;
156: 97-107
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.